Comparison of the in vitro transforming activities of human papillomavirus types
- PMID: 2458921
- PMCID: PMC457173
- DOI: 10.1002/j.1460-2075.1988.tb03013.x
Comparison of the in vitro transforming activities of human papillomavirus types
Abstract
The association of certain human papillomavirus (HPV) types with the majority of human cervical carcinomas suggests a role for the virus in the development of this type of cancer. In this paper, we have examined the transforming properties of several HPV types where the early region genes of the virus are under the control of a strong heterologous promoter and show that major differences exist between the HPV types in their ability to transform primary rat kidney epithelial cells in conjunction with an activated ras oncogene. Those HPV types most commonly found in carcinomas--types 16, 18, 31 and 33--are capable of co-operating with ras to transform primary cells, but those types most commonly found in benign lesions--types 6 and 11--are not. We further demonstrate that the E7 gene of HPV16 by itself is sufficient to co-operate with activated ras to produce transformed cells which are tumorigenic in immunocompetent animals.
Similar articles
-
Transformation of primary BRK cells by human papillomavirus type 16 and EJ-ras is increased by overexpression of the viral E2 protein.J Gen Virol. 1990 Jan;71 ( Pt 1):183-93. doi: 10.1099/0022-1317-71-1-183. J Gen Virol. 1990. PMID: 2154535
-
Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter.Virology. 1988 Jul;165(1):321-5. doi: 10.1016/0042-6822(88)90694-0. Virology. 1988. PMID: 2838969
-
Co-transformation by human papillomavirus types 6 and 11.J Gen Virol. 1990 Jan;71 ( Pt 1):165-71. doi: 10.1099/0022-1317-71-1-165. J Gen Virol. 1990. PMID: 2154533
-
Molecular mechanisms of transformation by the human papillomaviruses.Princess Takamatsu Symp. 1989;20:199-206. Princess Takamatsu Symp. 1989. PMID: 2562182 Review.
-
Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.Crit Rev Oncog. 1993;4(4):337-60. Crit Rev Oncog. 1993. PMID: 8394744 Review.
Cited by
-
Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras.EMBO J. 1989 Feb;8(2):513-9. doi: 10.1002/j.1460-2075.1989.tb03405.x. EMBO J. 1989. PMID: 2542020 Free PMC article.
-
The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.EMBO J. 1990 Jan;9(1):153-60. doi: 10.1002/j.1460-2075.1990.tb08091.x. EMBO J. 1990. PMID: 2153075 Free PMC article.
-
Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.J Virol. 1992 Aug;66(8):5100-5. doi: 10.1128/JVI.66.8.5100-5105.1992. J Virol. 1992. PMID: 1321290 Free PMC article.
-
Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.J Virol. 2006 Feb;80(4):1787-97. doi: 10.1128/JVI.80.4.1787-1797.2006. J Virol. 2006. PMID: 16439535 Free PMC article.
-
Effect of human papillomavirus type 16 oncogenes on MAP kinase activity.J Virol. 1995 Dec;69(12):8051-6. doi: 10.1128/JVI.69.12.8051-8056.1995. J Virol. 1995. PMID: 7494320 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources